Download the SITC 2018 Meeting App and get the most out of your 33rd Annual Meeting & Pre-Conference Programs experience.
Indianapolis | Minneapolis | Seattle New York City | Louisville, Ky. | Pittsburgh
The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.
Join a SITC Professional Interest Community
Create new collaborations, build your professional network and discuss the latest research trends in SITC Professional Interest Communities.
The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.
See members discuss the benefits of a SITC membership in this new video.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
The Cancer Center at Beth Israel Deaconess Medical Center will present two events focused on cancer immunotherapy in the month of October. All are invited. Standard of Cure Cancer Symposium, October 17 ...
Following the recent announcement of the Venue for Global Conference on Cancer & Oncology Research The World Cancer Congress 2019 will now be held in Dubai, at the Radisson Blu Hotel, Dubai Waterfront on 04-05 March 2019 For any enquiries regarding ...
This message was posted by a user wishing to remain anonymous October 26-27, 2018 Zuckerman Research Center New York City Systemic anticancer therapies including cytotoxic chemotherapies, targeted therapies, and immunotherapies have resulted ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org